Get the Stockscreener App
9.58
8.90%
-1.10
After Hours:
9.58
Benitec Biopharma Inc Stock (BNTC) Forecast
The Benitec Biopharma Inc (BNTC) stock price forecast for the next 30 days is generally negative, with an average analyst price target of $9.2333, representing a -3.62% decrease from the current price of $9.58. The highest analyst price target is $9.2281, and the lowest is $9.2384.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month BNTC Price Target
Average 10.24
(+6.90% Upside)
Is Benitec Biopharma Inc (BNTC) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 40.55 | Neutral |
| STOCH(9,6) | 53.69 | Neutral |
| STOCHRSI(14) | 46.06 | Neutral |
| MACD(12,26) | 0.0543 | Sell |
| ADX(14) | 32.03 | Sell |
| William %R | -86.42 | Buy |
| CCI(14) | -351.46 | Sell |
Buy: 1
Sell: 3
Neutral: 3
Summary: Neutral
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
10.49
Sell
|
10.43
Sell
|
| MA20 |
10.63
Sell
|
10.46
Sell
|
| MA50 |
9.9206
Sell
|
10.07
Sell
|
| MA100 |
9.4518
Buy
|
9.3553
Buy
|
| MA200 |
7.8284
Buy
|
7.9322
Buy
|
Buy: 4
Sell: 6
Neutral: 0
Summary: Sell
According to our latest analysis, BNTC could be considered a Strong Sell, with 17 technical analysis indicators signaling 5 Buy signals, 9 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on BNTC, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 40.55 indicates that BNTC is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 53.69 indicates that BNTC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 46.06 indicates that BNTC is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- ADX (Average Directional Index): The ADX value of The ADX value of 32.03 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -351.46 indicates that BNTC is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term BNTC price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Benitec Biopharma Inc financial reports and earnings history, Benitec Biopharma Inc (BNTC) stock could reach $23.39 by 2030, $26.28 by 2040 and $57.91 by 2050. See the projected annual prices until 2050 of the Benitec Biopharma Inc stock below:
- Benitec Biopharma Inc (BNTC) is expected to reach an average price of $10.86 in 2035, with a high prediction of $10.81 and a low estimate of $10.73. This indicates an $13.34% rise from the last recorded price of $9.58.
- Benitec Biopharma Inc (BNTC) stock is projected to chart a bullish course in 2040, with an average price target of $25.86, representing an $169.93% surge from its current level. The forecast ranges from a conservative $25.89 to a sky-high $26.28.
- Our analysts predict Benitec Biopharma Inc (BNTC) to jump 326.62% by 2045, soaring from $40.88 to an average price of $40.87, potentially reaching $41.19. While $40.88 is the low estimate, the potential upside is significant.
- Benitec Biopharma Inc (BNTC) stock is expected to climb by 2050, reaching an average of $57.41, a $499.26% jump from its current level. However, a wide range of estimates exists, with high and low targets of $57.91 and $57.55, respectively, highlighting the market's uncertainty.
Benitec Biopharma Inc Stock (BNTC) Year by Year Forecast
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2024
Our forecast for BNTC stock price in 2024 now indicates an average price target of $6.3686 with a high forecast of $10.05 and a low forecast of $2.69. The average prediction reflects an decrease of -33.52% from the last recorded price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| December, 2024 | $10.59 | $9.2384 | $9.2281 | +10.56% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2025
Benitec Biopharma Inc Stock (BNTC) is expected to reach an average price of $10.55 in 2025, with a high prediction of $12.84 and a low estimate of $8.2704. This indicates an +10.17% rise from the last recorded price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2025 | $10.90 | $11.33 | $10.49 | +13.81% |
| February, 2025 | $11.10 | $10.71 | $10.53 | +15.85% |
| March, 2025 | $10.80 | $11.02 | $10.03 | +12.71% |
| April, 2025 | $11.74 | $10.75 | $12.21 | +22.54% |
| May, 2025 | $3.9892 | $10.91 | $11.47 | -58.36% |
| June, 2025 | $9.0541 | $8.2704 | $8.2547 | -5.49% |
| July, 2025 | $8.2402 | $9.3802 | $9.5265 | -13.98% |
| August, 2025 | $9.5652 | $9.0027 | $8.8752 | -0.15% |
| September, 2025 | $8.6401 | $9.2176 | $8.6364 | -9.81% |
| October, 2025 | $9.6663 | $8.8413 | $9.315 | +0.90% |
| November, 2025 | $9.7712 | $10.39 | $9.8675 | +2.00% |
| December, 2025 | $13.12 | $13.04 | $12.84 | +36.92% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2026
The predicted value for Benitec Biopharma Inc (BNTC) in 2026 is set at an average of $11.18. Estimates vary from a peak of $12.76 to a trough of $9.5957, indicating an +16.67% surge from the present price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $12.67 | $12.96 | $12.76 | +32.28% |
| February, 2026 | $12.57 | $12.73 | $12.57 | +31.18% |
| March, 2026 | $11.67 | $11.85 | $12.09 | +21.84% |
| April, 2026 | $10.64 | $10.61 | $10.77 | +11.05% |
| May, 2026 | $11.49 | $11.78 | $11.56 | +19.97% |
| June, 2026 | $9.6181 | $9.7168 | $8.8781 | +0.40% |
| July, 2026 | $9.8442 | $10.06 | $9.963 | +2.76% |
| August, 2026 | $9.4391 | $9.5957 | $9.6454 | -1.47% |
| September, 2026 | $9.9753 | $9.9328 | $9.8453 | +4.13% |
| October, 2026 | $9.8502 | $10.15 | $9.8502 | +2.82% |
| November, 2026 | $9.5551 | $9.605 | $9.6614 | -0.26% |
| December, 2026 | $9.7013 | $9.6264 | $9.4276 | +1.27% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Benitec Biopharma Inc (BNTC) is $9.847, with a high forecast of $10.27 and a low forecast of $9.4286. This indicates an +2.79% increase from the last price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $9.4862 | $9.5562 | $9.5325 | -0.98% |
| February, 2027 | $9.6811 | $9.4286 | $9.3111 | +1.06% |
| March, 2027 | $9.8773 | $9.8536 | $9.4948 | +3.10% |
| April, 2027 | $9.8822 | $9.9385 | $9.6009 | +3.15% |
| May, 2027 | $9.5871 | $9.7671 | $9.7535 | +0.07% |
| June, 2027 | $9.7933 | $9.5483 | $9.702 | +2.23% |
| July, 2027 | $9.4732 | $9.7582 | $9.6622 | -1.11% |
| August, 2027 | $9.6531 | $9.5594 | $9.5519 | +0.76% |
| September, 2027 | $10.36 | $10.11 | $10.26 | +8.13% |
| October, 2027 | $10.27 | $10.32 | $10.27 | +7.25% |
| November, 2027 | $9.7991 | $9.9666 | $9.8879 | +2.29% |
| December, 2027 | $9.8828 | $9.9216 | $9.8851 | +3.16% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2028
In 2028, Benitec Biopharma Inc (BNTC) is projected to reach an average price of $8.9949, with a high projection of $10.01 and a low estimate of $7.9842. This indicates an -6.11% fall from the last price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $9.8554 | $9.8702 | $9.8677 | +2.87% |
| February, 2028 | $9.9734 | $9.9114 | $10.01 | +4.11% |
| March, 2028 | $9.9259 | $9.9302 | $9.946 | +3.61% |
| April, 2028 | $9.6962 | $9.7312 | $9.8626 | +1.21% |
| May, 2028 | $9.4894 | $9.5223 | $9.6374 | -0.95% |
| June, 2028 | $9.2338 | $9.2622 | $9.4245 | -3.61% |
| July, 2028 | $9.0022 | $9.0611 | $9.141 | -6.03% |
| August, 2028 | $8.7823 | $8.7871 | $8.9434 | -8.33% |
| September, 2028 | $8.6232 | $8.6331 | $8.7205 | -9.99% |
| October, 2028 | $8.4092 | $8.4475 | $8.5476 | -12.22% |
| November, 2028 | $8.1454 | $8.1843 | $8.3409 | -14.97% |
| December, 2028 | $7.9607 | $7.9842 | $8.1028 | -16.90% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2029
The 2029 price forecast for Benitec Biopharma Inc Stock (BNTC) is $5.375 on average, with a high prediction of $10.15 and a low estimate of $0.5971. This represents an -43.89% decrease from the previous price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $4.8754 | $4.97 | $7.8816 | -49.11% |
| February, 2029 | $5.3103 | $5.2891 | $4.8566 | -44.57% |
| March, 2029 | $4.4052 | $4.6752 | $4.7215 | -54.02% |
| April, 2029 | $3.9601 | $4.4401 | $4.3189 | -58.66% |
| May, 2029 | $3.7063 | $3.6551 | $3.8314 | -61.31% |
| June, 2029 | $3.7112 | $3.6572 | $3.5146 | -61.26% |
| July, 2029 | $3.5061 | $3.516 | $3.3979 | -63.40% |
| August, 2029 | $3.6823 | $3.4774 | $3.4611 | -61.56% |
| September, 2029 | $2.5172 | $3.5472 | $3.5435 | -73.72% |
| October, 2029 | $1.1034 | $1.1921 | $1.3484 | -88.48% |
| November, 2029 | $1.1317 | $0.5971 | $1.5617 | -88.19% |
| December, 2029 | $12.10 | $0.6605 | $10.15 | +26.32% |
Benitec Biopharma Inc Stock (BNTC) Price Forecast for 2030
Benitec Biopharma Inc Stock (BNTC) is expected to reach an average price of $21.13 in 2030, with a high forecast of $29.82 and a low forecast of $12.43. This signifies an +120.51% surge from the last price of $9.58.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $26.83 | $12.43 | $23.39 | +180.04% |
| February, 2030 | $27.73 | $28.18 | $27.42 | +189.42% |
| March, 2030 | $26.88 | $27.33 | $28.75 | +180.64% |
| April, 2030 | $27.54 | $28.59 | $26.69 | +187.49% |
| May, 2030 | $27.06 | $27.42 | $27.83 | +182.43% |
| June, 2030 | $28.02 | $28.02 | $27.16 | +192.44% |
| July, 2030 | $27.95 | $27.37 | $27.43 | +191.75% |
| August, 2030 | $29.79 | $29.04 | $28.44 | +211.00% |
| September, 2030 | $28.58 | $29.53 | $28.74 | +198.33% |
| October, 2030 | $28.55 | $28.76 | $28.48 | +198.06% |
| November, 2030 | $30.09 | $28.46 | $28.05 | +214.09% |
| December, 2030 | $29.80 | $29.96 | $29.82 | +211.02% |
4.27%
0.88%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):